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Background: Mortality from bacterial meningitis, predominately caused by Streptococcus
pneumoniae, exceeds 50% in sub-Saharan African countries with high HIV prevalence.
Underlying causes of high mortality are poorly understood. We examined the host and
pathogen proteome in the CSF of adults with proven pneumococcal meningitis (PM), testing
if there was an association between differentially expressed proteins and outcome.
Materials/Methods:CSF proteomes were analyzed by quantitative Mass-Spectrometry.
Spectra were identified using the Swissprot human and TIGR4 pneumococcal protein
libraries. Proteins were quantitated and analyzed against mortality. Unique proteins in PM
were identified against published normal CSF proteome. Random-Forest models were
used to test for protein signatures discriminating outcome. Proteins of interest were tested
for their effects on growth and neutrophil opsonophagocytic killing of S. pneumoniae.
Results:CSF proteomes were available for 57 Adults with PM (median age 32 years, 60%
male, 70% HIV-1 co-infected, mortality 63%). Three hundred sixty individual human and
23 pneumococcal proteins were identified. Of the human protein hits, 30% were not
expressed in normal CSF, and these were strongly associated with inflammation and
primarily related to neutrophil activity. No human protein signature predicted outcome.
However, expression of the essential S. pneumoniae protein Elongation Factor Tu (EF-Tu)
was significantly increased in CSF of non-survivors [False Discovery Rate (q) <0.001].
Expression of EF-Tu was negatively co-correlated against expression of Neutrophilgy | www.frontiersin.org December 2020 | Volume 10 | Article 6036231
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Frontiers in Cellular and Infection Microbiolodefensin (r 0.4 p p < 0.002), but not against complement proteins C3 or Factor H. In vitro,
addition of EF-Tu protein impaired S. pneumoniae neutrophil killing in CSF.
Conclusions: Excessive S. pneumoniae EF-Tu protein in CSF was associated with
reduced survival in meningitis in a high HIV prevalence population. We show EF-Tu may
inhibit neutrophil mediated killing of S. pneumoniae in CSF. Further mechanistic work is
required to better understand how S. pneumoniae avoids essential innate immune
responses during PM through production of excess EF-Tu.Keywords: meningitis, HIV—human immunodeficiency virus, mortality, Streptococcus pneumoniae, cerebrospinal
fluid, proteomics, Elongation factor Tu (EF-Tu)INTRODUCTION
Acute bacterial meningitis (ABM) is a leading cause of infectious
mortality and morbidity worldwide; an estimated 2.8 million
incident cases of community-acquired ABM were reported in
2016 occurring predominately in children and young people
(Collaborators GBDM, 2018). There is a particularly high toll of
meningitis caused by Streptococcus pneumoniae (pneumococcal
meningitis, PM) in sub-Saharan Africa, where the combination of
high HIV prevalence and high burden of nasopharyngeal carriage
create a potent environment for PM to flourish in all age groups
(Gessner et al., 2010; Heinsbroek et al., 2015; Britz et al., 2016;
Swarthout et al., 2020). Ambitious global WHO targets to defeat
meningitis by 2030 were published in 2018 (Organisation) WWH,
[[NoYear]]). However, progress in Africa is limited by the lack of
affordable vaccines and effective adjunctive therapies to antibiotics
(Scarborough et al., 2007; Ajdukiewicz et al., 2011; Wall et al.,
2017a). In African LMICs mortality from ABM in adults and
adolescents exceeds 50% compared to 10–20% in better resourced
settings, but causes of excessive mortality fromABM in this setting
are not well described (van de Beek et al., 2010; Mourvillier et al.,
2013; Wall et al., 2017a; Tenforde et al., 2019).
Prognostic scores for ABM have low sensitivity and specificity
(Weisfelt et al., 2008; Wall et al., 2017b), suggesting pathological
differences in the CNS leading to poor outcome are not readily
detected by clinical parameters. During PM, large numbers of
neutrophils rapidly trans-migrate from blood in response to pro-
inflammatory mediators in CSF (Potter and Harding, 2001;
Koedel et al., 2009; de Oliveira et al., 2016). Neutrophils have a
critical role in killing S. pneumoniae by phagocytosis (Ramos-
Sevillano et al., 2016; Ullah et al., 2017), but also contribute to
counter-productive inflammatory responses which may mediate
death and disability in pneumococcal meningitis, sepsis and
pneumonia (Bewley et al., 2011; Ramos-Sevillano et al., 2016;
Ritchie et al., 2018; Domon et al., 2018). This host-pathogen
interaction triggers an inflammatory cascade of both cytotoxic
effects of host pro-inflammatory mediators (Mook-Kanamori
et al., 2011; Wang et al., 2016), and bacterial toxins, that drive
tissue damage in non-survivors characterized by apoptotic
neuronal cell injury, raised intracranial pressure (ICP),
thrombosis, cerebral edema, and ischemia (Wall et al., 2012;
Wippel et al., 2013; Wall et al., 2014; Doran et al., 2016).gy | www.frontiersin.org 2Proteomics provides an opportunity to dissect this host-
pathogen interaction in CSF during disease by both
quantitating the relative abundance of multiple inflammatory
proteins, and testing for associations between human and
bacterial proteins and outcome (Zhang et al., 2015; Bastos
et al., 2017). Previously, the CSF proteome in a small number
of children with PM from our center showed marked
upregulation of multiple inflammatory and bacterial proteins
compared to hospital controls, including neutrophil proteins
S100A9 and myeloperoxidase in CSF (Gomez-Baena et al., 2017).
In an earlier study, using 2D electrophoresis proteomics of adults
with PM, demonstrated consumption of complement C3 in non-
survivor CSF, we described an exacerbated host response
including proteins involved with brain damage (Goonetilleke
et al., 2010; Goonetilleke et al., 2012), but did not find major
proteomic differences between the outcome groups.
In this study, we utilized label-free quantitative tandem mass-
spectrometry proteomics to quantitate the host and pathogen
proteome in adults with PM, to determine if a CSF protein
signature predicts the outcome from PM. We further tested the
effects of a protein associated with poor outcome using an in
vitro neutrophil killing assay.METHODS
Patients
CSF was obtained for proteomics from adults and adolescents on
admission to hospital with suspected bacterial meningitis at
Queen Elizabeth Central Hospital in Blantyre, Malawi between
2011 and 2013 (Wall et al., 2017a). All CSF samples were
collected prior to administration of parenteral antibiotics 2 g
BD for 10 days (Scarborough et al., 2007; Ajdukiewicz et al.,
2011). Clinical data were recorded on admission to hospital,
clinical outcome data reported at 6 weeks post-discharge (Wall
et al., 2017a).
Procedures
Routine CSF microscopy, cell count, and CSF culture was done at
the Malawi-Liverpool-Wellcome Trust Clinical Research
Programme laboratory in Blantyre, Malawi as previously
described (Wall et al., 2017a). Culture negative samples wereDecember 2020 | Volume 10 | Article 603623
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for S. pneumoniae, Neisseria. Meningitidis, and Haemophilus
influenzae type b (Hib) kit from Fast-Track Diagnostics (FTD
Luxemburg) according to the manufacturer’s instructions, bacterial
loads were estimated from Ct values. Additionally, CSF was
screened for Herpes viruses including EBV, CMV, and HSV1.
We excluded patients with active viral co-infection in the CSF. We
collected 2.0 ml of CSF for proteomics, stored on receipt in the
laboratory (within 2 h of LP) at −80 degrees Celsius. In-hospital
HIV testing was done on all patients by the clinical teams using
point-of care Genie™ HIV1&2 test kits (BioRad, USA).
CSF Protein Extraction
and Mass-Spectrometry
Protein concentration in all CSF samples was measured by
nanodrop (Thermo Scientific, UK) and normalized to 200 µg/
ml. Samples were centrifuged at 13,000 g and the pellet stored at
−80°C until peptide extraction. Proteins were treated with the
surfactant 0.1% (v/v) RapiGest™ (Waters) at 80°C for 10 min
followed by reduction with diothiothreitol (DTT) at a final
concentration of 3 mM (60°C for 10 min) and alkylation with
iodoacetamide (IAA) at a final concentration of 50 mM (room
temp, in the dark, 1 h). The enzyme trypsin (sequencing grade,
Promega) was added at an enzyme:substrate ratio of 1:50 and
incubated overnight with agitation at 37°C. The surfactant was
inactivated the following day by treatment with 0.1%
trifluoroacetic acid (TFA) (37°C for 1 h) and peptides were
recovered following centrifugation at 13,000 g.
Resultant CSF peptides were separated by RPLC using a
DIONEX UltiMate™ 3000LC chromatography system and
MSMS analysis performed on an LTQ Orbitrap Velos using
Xcalibur software v2.1 (both Thermo Scientific, UK). Peptides
(10 µl = ~500 ng) were injected onto the analytical column
(Dionex Acclaim® PepMap RSLC C18, 2 µm, 100 Å, 75 µm i.d.
×15 cm, nanoViper.), which was maintained at 35°C and at a
nanoflow rate of 0.3 µlmin−1. Peptides were separated over linear
chromatographic gradients composed of buffer A (2.5% ACN:
0.1% FA) and buffer B (90% ACN: 0.1% FA). Two gradients, 60
(3–50% buffer B in 40 min) and 180 min (3–60% buffer B in 140
min), were employed for analysis. Full scan MS spectra were
acquired over the m/z range of 350–2,000 in positive polarity
mode by the Orbitrap at a resolution of 30,000. A data-
dependent Top20 collision induced dissociation (CID) data
acquisition method was used. The ion-trap operated with CID
MSMS on the 20 most intense ions (above the minimum MS
signal threshold of 500 counts).
Bio-informatic Quantitative Analysis
Data was initially mass recalibrated using the mzRefiner filter of
the Proteowizard msconvert tool. The resulting files were then
processed using Progenesis QI (version 2 Nonlinear Dynamics,
Newcastle upon Tyne, UK). Samples were aligned according to
retention time using a combination of manual and automatic
alignment. Default peak picking parameters were applied and
features with charges from 1+ to 4+ featuring three or more
isotope peaks were retained. Database searching was performedFrontiers in Cellular and Infection Microbiology | www.frontiersin.org 3using Mascot (Matrix Science, London, UK). A Mascot Generic
File, created by Progenesis QI, was searched against a merged
database of the reviewed entries of the Uniprot reference
proteome set of H. sapiens (09/12/2015, 20,187 sequences) and
S. pneumoniae (09/12/2015, 2,030 sequences). A fixed
carbamidomethyl modification for cysteine and variable
oxidation modification for methionine were specified. A
precursor mass tolerance of 10 ppm and a fragment ion mass
tolerance of 0.6 Da were applied. The results were then filtered to
obtain a peptide false discovery rate of 1%. Protein inference and
quantification was performed using the “Relative Quantitation
using non-conflicting peptides” option in Progenesis. Protein
quantification values are determined from all peptides but
weighted according to peptide intensity. Proteins were annotated
as differentially expressed if they achieved an FDR corrected
q value of 0.05. Outcome prediction was performed by random
forest using the cforest function of the “party” package in R.
Pathways analysis of proteins was done using Innate DB.
Synthesis of Pneumococcal Proteins
E. coli cells containing pEQ30_EF-Tu were kindly donated by
Prof. Sven Hammerschmidt. E. coli was grown at 25°C in LB
supplemented with 100 µg/ml ampicillin (Mohan et al., 2014).
When the OD595nm reached 0.5, protein expression was induced
by adding 1 mM isopropyl b-d-thiogalactoside (IPTG). EF-Tu
was modified to contain a polyhistidine tag to aid purification
and detection. EF-tu is insoluble when expressed in E. coli and
precipitates in inclusion bodies. Firstly, the cells were pelleted by
centrifugation at 3,250 × g, then the pellet was resuspended in 10
ml of 50 mMNaH2PO4, 300 mMNaCl (pH 8). This was followed
firstly by sonication and then by centrifugation at 4,300 × g, for
30 min at 4°C. The pellet containing the inclusion bodies was
then washed in 50 mM NaH2PO4, 300 mM NaCl (pH 8) and
resuspended in 500 µl of 50 mM NaH2PO4, 300 mM NaCl, 4 M
Urea (pH 8) to solubilize the inclusion bodies. This suspension
was then centrifuged at 18,000 × g for 30 min at 4°C. The
supernatant that contained EF-Tuf was then mixed with Ni-NTA
(Qiagen, Germany) that had been resuspended in the same buffer
as the protein. The column was then washed with 10 column
volumes (CV) of 50 mM NaH2PO4, 300 mM NaCl, 4 M Urea
(pH 8). The protein was eluted with 6 CV’s using 50 mM
NaH2PO4, 300 mM NaCl, 4 M Urea, 250 mM immidazole (pH
8). Eluted EF-Tuf was refolded by dialysis in 20 mM Tris-HCl 5
mM MgCl2 pH 7.4. Finally, the protein was recovered, and the
buffer exchanged into PBS during concentration. Presence of the
protein was confirmed via an anti-His western blot. Identity of
the protein of choice was confirmed by running an anti-His
western blot of the cell lysates prepared in the presence and
absence of IPTG. Non-induced cell extracts did not react with
anti-his antibody (Supplementary Figure 1).
Bacterial Growth Conditions
Strains of S. pneumoniae serotype 1 ST5316 (Terra et al., 2020)
were grown in Todd-Hewitt broth supplemented with 0.5% yeast
extract (THY) to OD 0.5 and stored in 80% glycerol at −80°C as
previously described (Ramos-Sevillano et al., 2012). BacteriaDecember 2020 | Volume 10 | Article 603623
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ml in either pooled serum from five healthy laboratory donors
(non-PCV vaccinated) or thawed human cerebrospinal fluid
(CSF). CSF was obtained from patients who underwent
therapeutic lumbar puncture for idiopathic intracranial
hypertension, all had biochemically normal, acellular CSF. CSF
was kindly donated by Professor Diederik van de Beek
(Amsterdam Medical Centre, Netherlands). Four ug of purified
EF-Tu, bovine serum albumin (BSA), NanA or PiaA or PBS
control were added to five technical replicates.
Growth for 24 h was detected by changes in optical density at
620 nmwith shaking in a microplate reader (Tecan®USA) at 37°C.
Opsonophagocytosis Assays
Bacterial killing by purified human neutrophils was done using a
previously described opsonophagocytosis assay (Hyams et al.,
2010). Briefly, neutrophils were extracted from whole blood of
healthy donors by negative selection Maxspress kit (Milteyni
biotech, USA) according to the manufacturer’s instructions.
Bacteria were opsonized in either 10% pooled serum or CSF
for 30 min at 37°C then incubated with purified fresh human
neutrophils in HBSS with either 4 ug of purified EF-Tu, BSA, or
PBS at 37°C for 45 min with shaking in the dark. Cytochalasin D
was included in the negative control to stop phagocytosis. Serial
dilutions of the reaction mix were plated on Colombia agar
supplemented with 5% horse blood, and colony forming units
(CFU) counted after 18 h incubation at 37°C.
Statistical Methods
All conventional statistical tests were two tailed, alpha <0.05
determined statistical significance. Ninety-five percent confidence
intervals are presented for odds ratios. Logistic regression was used
to model associations between clinical outcomes and risk factors
while controlling for confounding factors.
Data Deposition
All proteomic data was submitted to the ProteomeXchange:
Accession number:
Submission Reference: 1-20200901-167440
Submission Path:/nfs/pride/drop/pride-drop-003/
philipjb_20200901_134730
Ethical Approvals
All participants or nominated guardians gave written informed
consent for inclusion. Ethical approval for the transcriptomicsFrontiers in Cellular and Infection Microbiology | www.frontiersin.org 4study was granted by both the College of Medicine Research and
Ethics Committee (COMREC), University of Malawi (P.01/10/
980, January 2011), and the Liverpool School of Tropical
Medicine Research Ethics Committee, UK (P10.70, November
2010) Committee, Liverpool, UK.RESULTS
Patients
Fifty-seven patients with proven PM, whose CSF was stored within
4 h of presentation to hospital, were included in the study, 33 (57%)
of whom had died within 6 weeks (Table 1). Median age was 33
years (IQR 26–44), and predominantly HIV co-infected (34/47,
72%). CSF protein and bacterial loads were high, and although
raised, the CSF white cell counts (WCC) were substantially lower
than those reported in high income settings (Costerus et al., 2016)
(Table 1). Neither CSF bacterial load, CSF protein, nor CSF WCC
differed significantlybetween survivors andnon-survivors inanun-
adjusted analysis. Similarly, to our previous reports, GlasgowComa
Score (GCS) was significantly lower in non-survivors (11/15) than
survivors (14/15) (OR 0.57, 95%CI 0.35–0.87) on admission (Wall
et al., 2017b).
CSF Human Proteome
A total of 336 peptides matching Uniprot identifiers were found
in the CSF (Figure 1, Supplementary Data 1). Albumin was the
most abundant CSF protein, followed by sub-classes of
immunoglobulins, complement C3, alpha-1 antitrypsin,
haptoglobin, hemopexin, and neutrophil proteins S100A8&9
(Table 2). Overall, the most abundant protein classes were
immunoglobulins, metabolic proteins, and complement, along
with antigen-binding proteins, neutrophil-associated and anti-
bacterial proteins, inflammatory response, and vasomotor tone.
Blood brain barrier (BBB) breakdown was suggested by the
identification of hemoglobin, haptoglobin, and fibrinogen in
the CSF (Figure 1). Pathways analysis of the entire proteome
(Innate DB) found 16 pathways enriched with q < 0.05,
dominated by complement, platelet degranulation, scavenging
of heme, and axon guidance pathways (Table 3).
Sub-Set of Proteins Unique to PM
When compared to two reports of the proteome in normal CSF
(Guldbrandsen et al., 2014; Zhang et al., 2015), we found 130/336
(38%) of proteins in PM were not normally found in CSF (FigureTABLE 1 | Demographic details of included participants.
Survivors (n = 19) Non-survivors (n = 33) OR Survival p
Bacterial load (log10) 4.7 × 10
6
(7.7 × 105–3.5 × 107)
1.4 × 107
(9.8 × 105–6.8 × 107)
1.1 (0.83 : 1.56) 0.5
Age (years) 30 (26–41) 36 (24–44) 1.02 (0.96 : 1.06) 0.3
Male gender 11 (58%) 21 (63%) 0.78 (0.24 : 2.4) 0.68
GCS 14 (13–15) 12 (8–13) 0.57 (0.35 : 0.85) 0.007
CSF WCC cells/mm3 52 (2–1760) 27 (2–287) 0.83 (0.43 : 1.5) 0.56
CSF protein (g/dl) 3.02 (2.5–4.0) 2.52 (1.8–5.6) 1.1 (0.7 : 1.7) 0.63
HIV infection 10/16 (62%) 24/31 (77%) 0.48 (0.1 : 1.8) 0.28December 2020 | Volume 10 | Article 603623
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neutrophil and inflammatory proteins, CNS proteins, hemoglobin,
and somemetabolic proteins (Figure 2B). Pathways analysis of this
protein set unique to PM was strongly enriched for complement
activity, hemostasis and heme activation, neutrophil and platelet
degranulation, actin dynamics, and scavenger receptor binding
(Table 4). We also identified 10 proteins with a primary CNS
source including BSAP1, APLP1, CHL1, mapping to pathways
including Axon guidance and Dorso-ventricular axis.
CSF Streptococcus pneumoniae Proteome
Of the 30 pneumococcal proteins detected in CSF, four proteins
were structural, ten related to metabolic activity, eight were
ribosomal proteins, and nine had primary functions in virulence,
or the stress response. These included the virulence factor PspATABLE 2 | Estimated abundance (arbitrary quantitative units) of 20 most highly expressed proteins in the CSF of patients with PM.
# Protein Median protein abundance (units) # Protein Median protein abundance
1 Serum albumin 2.02E+09 13 Hemopexin 4.86E+07
2 Ig gamma-1 chain C region 1.39E+09 14 Apolipoprotein A-I 3.24E+07
3 Ig kappa chain C region 6.02E+08 15 Fibrinogen gamma chain 2.63E+07
4 Immunoglobulin lambda-like polypeptide 5 2.91E+08 16 Protein S100-A9 2.51E+07
5 Alpha-1-acid glycoprotein 1 1.33E+08 17 Alpha-2-macroglobulin 2.49E+07
6 Ig lambda-2 chain C 1.25E+08 18 Ig heavy chain V-III region BRO 2.46E+07
7 Haptoglobin 1.09E+08 19 Neutrophil defensin 1 2.25E+07
8 Alpha-1-antitrypsin 9.06E+07 20 Alpha-1-acid glycoprotein 2.11E+07
9 Ig alpha-1 chain C region 9.04E+07 21 Complement C3 2.10E+07
10 Serotransferrin 8.65E+07 22 Vitamin D-binding protein 2.09E+07
11 Ig gamma-3 chain C region 6.67E+07 23 Protein S100-A8 1.91E+07
12 Ig gamma-2 chain C region 6.39E+07 24 Ig mu heavy chain disease protein 1.88E+07December 2020FIGURE 1 | The CSF proteome in pneumococcal meningitis is diverse and highly inflammatory. Bubble plot summary of the CSF proteome in pneumococcal
meningitis. Three hundred thirty-six peptides identified by Mass-Spectrometry. Green, cellular functional proteins; blue, proteins synthesized by white and plasma
cells; purple, complement and clotting cascades; orange, pro-inflammatory proteins.TABLE 3 | Enrichment of 10 most highly expressed biological pathways in the
CSF of patients with PM.
Pathway
number
Pathway name P-adj value
enrichment
1 Innate immune system 3.23E-73
2 Immune system 3.72E-61
3 Complement cascade, Regulation of complement
cascade
3.29E-59
4 Hemostasis 7.66E-53
5 Neutrophil degranulation 3.29E-43
6 Scavenging heme from plasma 4.16E-41
7 RHO GTPases activate PKNs (actin dynamics) 1.70E-39
8 Binding and Uptake of Ligands by Scavenger
Receptors
2.77E-39
9 Classical antibody-mediated complement activation 1.23E-36
10 Platelet degranulation 7.48E-36| Volume 10 | Article 603623
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manganese transporter lipoprotein PsaA (required for protection
against oxidative stress), ABC transporter component GalT1
(released during opsonophagocytosis, associated with avoidance
of mucosal immunity) (Matthias et al., 2008), and the multi-
functional protein Elongation Factor Tu (EF-Tu) (Table 4).
The Human Proteome Did Not Predict
Outcome
To investigate the hypothesis that lower GCS reflects worsening
inflammation in the CNS, we used a Random Forest model to test
for a protein signature to predict outcome in CSF. Principal
component analysis of the CSF proteome in PM did not show
any separation between outcome groups testing either peptides or
proteins (Figure 3A). We were unable to detect any sub-set or
“signature” of proteins that correlated with outcome status (Figure
3B). The RandomForest Accuracywas 0.68 (95%CI 0.54–0.88), no
information rate (NIR) 0.61, p-value (Accuracy >NIR) = 0.16. We
then tested for associations with individual proteins that may be
associated with clinical outcome status (Figure 3C). A number of
host proteinswere over-expressed in theCSFof eitherpatient group
(Supplementary Figure 2) at an individual level, including S100A8
and CD163. However, none were significantly expressed at >1 log
fold change from the mean with FDR <0.05.
Poor Outcome Was Associated With
Higher Levels of the Streptococcus
pneumoniae Protein Elongation Factor Tu
Although the humanCSF proteomedid not correlatewith outcome
in PM, two S. pneumoniae proteins identified in the CSF did exceed
adjusted FDR significance threshold in non-survivor CSF on the
individual association analysis. These were Q8CWR9 (a ribosomal
protein) and Elongation Factor Tu (EF-Tu, P64031) (Figure 3C).
EF-Tu is an immunogenic surface expressed S. pneumoniae protein
(Thofte et al., 2018; Nagai et al., 2019), involved in the transport of
amino acylated tRNA components to ribosomes and is thought toA
B
FIGURE 2 | Highly abundant CSF proteins in pneumococcal meningitis are
directly involved in the host-pathogen interaction and demonstrate evidence
of blood-brain barrier breakdown. Venn diagram showing overlap between
the uniport peptide hits from the proteome of patients with PM and two
previously published proteomes of normal CSF (A). Bubble plot showing
breakdown of proteins found in the subset of proteins unique to PM n = 130
from Figure 1 (B). Green, cellular functional proteins; blue, proteins
synthesized by white and plasma cells; purple, complement and clotting
cascades; orange, pro-inflammatory proteins.TABLE 4 | Abundance and function of pneumococcal proteins in the CSF of patients with PM, in order of abundance.
Protein Function Estimated abundance
(units)
Protein Function Estimated abundance
(units)
1 Elongation factor Tu Multi-function 9.20E+05 11 Thioredoxin Stress response 4.46E+04
2 Chaperone protein DnaK Protein folding 2.52E+05 12 Enolase Carbohydrate
degradation
4.05E+04
3 Ribosomal proteins (n=8) Ribosome 1.80E+05 13 Acyl carrier protein Lipid metabolism 3.83E+04
4 Pyruvate oxidase Metabolism 1.60E+05 14 Endo-
Peptidase O
Virulence 2.16E+04
5 Ketol-acid reductoisomerase Metabolism 1.36E+05 15 ABC transporter
GalT1
Metabolism 1.52E+04
6 Glyceraldehyde-3-phosphate
dehydrogenase
Metabolism,
immuno-stimulant
1.09E+05 16 Phosphoglycerate
kinase
Metabolism 1.30E+04
7 Histone-like DNA-binding protein DNA stabilization 1.08E+05 17 Pyruvate kinase Metabolism 2.96E+03
8 Manganese ABC transporter
substrate-binding lipoprotein
Surface antigen 1.03E+05 18 Uncharacterized
protein
Unknown 2.54E+03
9 Glutamate dehydrogenase Metabolism 4.78E+04 19 General stress
protein GSP-781
Stress response 2.23E+03
10 Elongation factor G Translation and
collagen binding
4.64E+04 20 Surface protein
pspA
Virulence and
surface antigen
2.8E+03December 2020 | Volume 10 | Article 603623
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S. pneumoniae evasion of complement-mediated immunity
(Mohan et al., 2014).EF-Tu May Inhibit Neutrophil
Opsonophagocytosis in
Cerebrospinal Fluid
To further investigate the possible effects of EF-Tu on the host-
pathogen interaction in PM, we tested for statistical correlations
within with host proteins from the 130 unique PM protein
dataset. EF-Tu did not positively correlate with any humanFrontiers in Cellular and Infection Microbiology | www.frontiersin.org 7CSF proteins, but did negatively correlate with levels of
neutrophil defensin (r2 −0.06, p < 0.01) (Figure 4A). Mean
CSF levels of EF-Tu in non-survivors were 2.88 log2-fold higher
[1.77 × 106 units/ml (Std 1.38 × 106)] compared to 1.64 × 105
units/ml CSF (Std 3.4 × 105) in survivors (ANOVA p −0.05 ×
105. In contrast, CSF levels of neutrophil defensin in survivors
was 5.76 × 107 (Std 5.61 × 107) compared to 2.4 × 107 (Std 4.2 ×
107) in non-survivors (ANOVA p 0.008).
Addition of recombinant EF-Tu did not alter growth of
Serotype 1 ST5316 in THY, pooled human serum or hCSF
(five technical replicates, three experiments), suggesting no
significant effects of EF-Tu on autolysis in vitro (Nagai et al.,A
B
C
FIGURE 3 | Protein signatures in CSF do not predict outcome from PM, but individual pneumococcal proteins are highly expressed in non-survivors. CSF proteome
does not separate by outcome group (A). Principal component analysis of the CSF protein hits. Dot, individual patients; blue, survivor; and purple, non-survivor.
Summary plot of Random Forest analysis of highly abundant individual CSF peptide hits (B). Dot per protein shows deviation away from the mean (x axis) toward
non-survival. No cluster/signature of abundant proteins accurately predicts outcome in CSF. Quantitative volcano plot of all protein hits (C). Dots represent proteins.
Red, non-significantly expressed; blue, significantly expressed (FDR < 0.01). Dot size represents quantitative estimates of abundance.December 2020 | Volume 10 | Article 603623
Wall et al. EF-Tu in Pneumococcal Meningitis2018) (Figure 4B). Hence, we tested if EF-Tu had a negative
effect on the interaction between S. pneumoniae and neutrophils
in a human CSF model of neutrophil killing. When
S. pneumoniae were opsonized with pooled human serum,
addition of recombinant EF-Tu to the reaction mix did not
impair neutrophil killing. However, when bacteria were
opsonized with CSF, addition of EF-Tu caused a reduction in
S. pneumoniae killing compared to PBS control and resulted in a
similar effect to inhibition of phagocytosis by cytochalasin D
(Figure 4C).
DISCUSSION
The pathogenesis of PM is dominated by a rapid and intense
inflammatory response within the CSF compartment driven
by an influx of neutrophils reacting to the presence of
S. pneumoniae. Here, we show the highly inflammatory nature
of the proteome in PM on admission to hospital, containing both
brain- and blood-derived proteins, but the proteome does not
differ between patients who survive and those who subsequently
die. Over-expression of bacterial proteins in non-survivors may
reflect adaptation of S. pneumoniae to the survival in the CSF
compartment, that may have negative effects on the innate
immune response in PM that requires further investigation.
Human and animal data have shown that the rapid
neutrophil influx and the synthesis of antimicrobial peptides
triggers the release of highly damaging proteins including tissue
proteases (Tuomanen et al., 1985a; Tuomanen et al., 1985b) that
in some patients are thought to result in BBB breakdown,
cerebral thrombosis, and edema, thereby increasing mortality
(Roine et al., 2015; Savonius et al., 2018). We have now replicated
our earlier, smaller studies one in children and one in adults of
the proteome during PM (Gomez-Baena et al., 2017)30,31, using
high-throughput quantitative proteomics (Bastos et al., 2017).
This method enabled us to estimate abundance of individual
proteins, thus determining the most abundant proteins in CSF
during PM for the first time (Distler et al., 2016). By adjusting for
abundance and using high sensitivity acquisition, we were able to
detect all spectra present in CSF and confirm definitively that
CSF proteins, whilst highly inflammatory, do not differ between
survivors and non-survivors of PM.
Patients in our study were typical for PM patients in Africa,
young adults and adolescents, the majority co-infected with HIV,
with low CSF WCC and high CSF pneumococcal loads on
admission to hospital (Tenforde et al., 2019). As we have
previously reported (Wall et al., 2014), neither the bacterial
load, CSF WCC and protein concentration, or the HIV status
were associated with outcome in our patients. The CSF in
patients with proven PM is highly inflammatory. We detected
both expansion of the anti-infective components of CSF
(immunoglobulins and complement) and high levels of
expression of neutrophil-associated proteins including S100A8/
9, cathepsin, neutrophil defensin, and matrix-metalloproteinases
9 (MMP9) that infection models have suggested are detrimental
to the host (Tuomanen et al., 1989; Roine et al., 2014; Mohanty
et al., 2019). Severe BBB breakdown has previously been assumedFrontiers in Cellular and Infection Microbiology | www.frontiersin.org 8to be a pre-morbid event in PM (Barichello et al., 2011; Prager
et al., 2017), and quantifying BBB breakdown in patients is
complex (Helms et al., 2016; Prager et al., 2017; Natarajan et al.,
2017). In this dataset, which is controlled for protein abundance,
the presence of both brain-derived proteins (e.g. axonal
proteins), combined with serum components like hemoglobin,
haptoglobin, hemopexin, and fibrinogen, strongly suggest
breakdown of the BBB is evident on admission to hospital with
PM. We hypothesized that lower GCS on admission was related
to worsening BBB breakdown and cerebral inflammation, but
this was not supported by the CSF proteome. Our previous study
on Malawian adults with PM using unadjusted 2D page
proteomics suggested C3 and transferrin were reduced in non-
survivor CSF (Goonetilleke et al., 2010; Goonetilleke et al., 2012),
and data from The Netherlands also suggested that complement
activity in CSF was associated with worse clinical outcomes
(Mook-Kanamori et al., 2014; Kasanmoentalib et al., 2015;
Kasanmoentalib et al., 2017; Kasanmoentalib et al., 2019).
Whilst we demonstrated marked expansion of C3 and
transferrin in CSF, after adjusting for overall protein abundance
and composition these proteins did not correlate with outcome.
These earlier reports were tested only for individual associations
between proteins and outcome and were not adjusted for
abundance, introducing potential confounding. We also tested if
other human CSF proteins singly or in combination using
Random Forest models predicted outcome but found no
statistically significant association with mortality. The lack of
any predictive protein signature suggests that measuring static
inflammation through proteins does not reveal the complexity of
the host-pathogen interactions associated with tissue damage.
Clinical outcomes may instead be associated with dysfunctional
processes such as ineffective opsonophagocytosis which are not
readily identified by the abundance of specific proteins (Andre
et al., 2017; Campos et al., 2017; Ullah et al., 2017; Wright et al.,
2017; Lowe et al., 2018; Ritchie et al., 2018).
Compared to the abundance of host proteins, the number of
pathogenic proteins identified in our study was relatively small;
this probably reflects the relative abundance of bacteria and
host cells within the infected CNS. The number and range of
S. pneumoniae proteins identified in the CSF were similar to our
earlier study, including PspA, abundant ribosomal proteins and
EF-Tu (Gomez-Baena et al., 2017). These proteins differ from
those identified in a CSF proteome study in a murine model of
PM (Schmidt et al., 2019), in which high CSF levels of the
competence regulator ComDE and the AliB oligopeptide
transporter in murine meningitis were associated with
leukocyte recruitment to the CSF compartment and disease
severity (Schmidt et al., 2019). However, we did not detect
either expression of ComDE or AliB in patient PM CSF, and
we also did not detect other, previously reported virulence
proteins in PM including pneumolysin (Wall et al., 2012;
Wippel et al., 2013). The very limited number S. pneumoniae
proteins detected in this study may be because the abundance of
most S. pneumoniae proteins were below the limit of detection,
proteomics is a relatively insensitive method of assessing
bacterial activity during human PM.December 2020 | Volume 10 | Article 603623
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FIGURE 4 | EF-Tu negatively correlates with neutrophil defensin in CSF, and effects on neutrophil-mediated killing in CSF but not serum. (A) EF-TU negatively
correlates with neutrophil defensin. Estimates of the abundance of Tuf (x axis, log10 scale) plotted against abundance of highly expressed proteins (y axis, log10 scale)
known to interact with S. pneumoniae (complement C3, Factor H), and the most highly abundant neutrophil protein, Neutrophil defensin (A). Correlation estimated
with Spearman’s test. (B) EF-Tu does not enhance ST5316 growth in CSF, serum or THY. Growth curves of S. pneumoniae serotype 1 strain ST5316 in Todd-
Hewitt broth supplemented with 0.5% yeast extract (THY), pooled human serum and human CSF. Growth plotted over time (x axis) against optical density (y axis) at
620 nm. Growth in normal CSF compared to growth supplemented with 40 ug of recombinant EF-Tu. Additional proteins used as controls, bovine serum albumin
(BSA), neuroaminidase A (NanA), and pneumococcal iron acquisition system A (PiaA). (C) EF-Tu effects on neutrophil mediated killing of S. pneumoniae in CSF but
not serum. Viable S. pneumoniae strain ST5316 after 45 min neutrophil opsonophagocytosis assay, supplemented with 400 ug of recombinant Tuf protein. Bacteria
opsonized with serum (left panel) and CSF (right panel). Viability measured by colony forming unit (CFU) counts on blood agar after 18 h incubation. Data expressed
as medians with range. Statistical significance calculated using the Mann-Whitney U test.Frontiers in Cellular and Infection Microbiology | www.frontiersin.org December 2020 | Volume 10 | Article 6036239
Wall et al. EF-Tu in Pneumococcal MeningitisDespite the lack of sensitivity of the S. pneumoniae CSF
proteomics, we found that higher CSF levels of EF-Tu and the
ribosomal protein Q8CWR9 were associated with mortality. The
over-expression of these proteins in non-survivor CSF is an
important finding, and suggests a pathological role during PM.
Both proteins are important for S. pneumoniae replication, and
perhaps therefore reflect rapid bacterial growth as a driver for
poorer outcomes. EF-Tu is an essential, highly abundant,
ubiquitous bacterial protein, found in diverse prokaryotic species
including enterobacteriaceae, Pseudomonas, Staphylococci, and
Hemophilus spp (Harvey et al., 2019). While the primary function
of EF-Tu is transport of amino acylated tRNA components to the
ribosome, this protein has also been shown to have a surprisingly
varied rangeofmoonlighting functions indifferent bacterial species,
including some that affect virulence. EF-Tu can be anchored to the
bacterial cell surface, adhere to extracellular components including
complement factors (Mohan et al., 2014), chaperone bacterial
virulence proteins to the cell surface in membrane vesicles
(Olaya-Abril et al., 2014), promote adhesion and invasion of host
cells, and alter bacterial shape viapost-translationalmodification of
bacterial proteins (Harvey et al., 2019). S. pneumoniae EF-Tu can
bind complement factors H and related proteins Factor HL1 and
CFHR1, and plasminogen, has effects on autolysis even provides
potent antigen stimulation in an experimental pneumococcal
vaccine (Mohan et al., 2014; Nagai et al., 2018; Thofte et al., 2018;
Harvey et al., 2019; Nagai et al., 2019).We investigatedwhether EF-
Tu levels in the CSF correlated with complement proteins, proteins
associatedwith BBBbreakdownorneutrophil proteins found in the
humanCSF proteome. Levels of EF-Tudid not correlate with either
complement C3 or Factor H (Kasanmoentalib et al., 2019), but did
negatively correlate with neutrophil defensin, suggesting a possible
interaction with neutrophil opsonophagocytosis in CSF. No
correlation was found with other neutrophil proteins in CSF
including neutrophil elastase, collagenase, and lipocalin-1.
Neutrophil defensins are multi-functional immunomodulatory
proteins with direct anti-microbial activity (Voglis et al., 2009). We
tested the hypothesis that excessive EF-Tu effected on neutrophil
killing inCSF,finding that EF-Tupromotedbacterial survivalwhen
opsonized with CSF but not with serum. The Pseudomonas
aeruginosa EF-Tu promotes neutrophil apoptosis both in vitro
and in vivo murine pneumonia models an effect that was thought
to be mediated by oxygen sensing prolyl hydroxases recognition of
EF-Tu (Dickinson et al., 2017). EF-Tu from S. pneumoniae may
have a similar effect, leading to reduced neutrophil function,
especially in the conditions found within CSF compared to
serum. Alternatively, functions of EF-Tu may be more effectively
attenuated in serum due to components not present in CSF.
However, these hypotheses will need more detailed investigation
to confirm the association of EF-Tu with mortality and the
underlying mechanism(s) involved.LIMITATIONS
Patients in our study were predominately HIV co-infected, and we
were unable todiscriminatewhich inflammatoryCSFproteinswere
directly related to HIV infection rather than PM due to the smallFrontiers in Cellular and Infection Microbiology | www.frontiersin.org 10number of HIV-negative participants. Neither control CSF nor
validated CSF proteomic libraries from healthy individuals living
with HIV were available (Wall et al., 2017a). However, data from
our center suggests no differences in the transcriptome of children
with PM between HIV negative and children living with HIV
(Kulohoma et al., 2017). We were unable to stratify HIV co-
infected patients by CSF HIV viral load or CD4 count, but all
were classified as WHO AIDS Stage 3 with advanced disease. We
actively excluded patients with viral co-infection in CSF; infection
with hepatitis viruses is common in our setting, and could also
potentially through indirect effects on immune function increase
the heterogeneity of our host CSF proteomic data. Although we
detected an abundance of inflammatory proteins, including those
known to be associated with poor outcomes in other studies of PM,
we did not detect any cytokines and chemokines known to be
present inCSF (Mai et al., 2009; Bociaga-Jasik et al., 2012; Coutinho
et al., 2013; Grandgirard et al., 2013; Wall et al., 2014; Roine et al.,
2015; Srinivasan et al., 2016).Cytokines andchemokinesmaybe too
rapidlydegraded tobe assessedusingmass-spectrometry compared
withmore sensitive techniques such asELISA (Kupcova Skalnikova
etal., 2017).Visibly traumatic, blood stainedCSFwas rejectedby the
laboratory for analysis, however we cannot exclude microscopic
blood contamination as a source of CSF hemoglobin/haptoglobin.
After extractionofproteins for this study, insufficientCSF remained
to validate our findings by measuring CSF levels of EF-Tu by an
alternativemethod. Supporting theproteomedata, ourunpublished
data on gene expression demonstrated high levels of expression of
EF-Tu inbothpatientCSF andduringS. pneumoniae culture inCSF
in vitro (unpublished data). Finally, our data are from a single time
point, and we cannot determine if dynamic changes in human or S.
pneumoniae CSF protein predict outcome.CONCLUSIONS
The CSF proteome in PM is highly inflammatory with evidence
of BBB breakdown, but we did not find a human protein
signature correlated with clinical outcome. However, higher
levels of the S. pneumoniae ribosomal protein and EF-Tu were
found in non-survivor CSF, and in vitro EF-Tu may inhibit
neutrophil killing of S. pneumoniae in CSF. To better understand
the causes of mortality in PM, the role of EF-Tu requires further
investigation, using models that accurately reflect conditions in
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SUPPLEMENTARY FIGURE 1 | Confirmation of expression of recombinant
pQE30 EF-Tu from E. coli 2 and 24 h after protein induction. (A) Image of a Ponceau
Western membrane showing the presence of pQE30_EF-Tu. E. coli containing an
pQE30 tagged EF_Tu plasmid. (B) Image of a Coomassie stained Western
membrane showing the same. Data show experiments in parallel from induced, and
non-induced controls. From left to right Ladder, with 55 and 35 KD points indicated
respectively. Lane 1 Non-induced isolates, prior to induction. Lane 2 Induced
isolates, prior to induction. Lane 3 non-induced isolates, 2 h post induction, Lane 4
induced isolates, 2 h post induction. Lane 5 non-induced isolates, 24 h post
induction, Lane 6 induced isolates, 24 h after induction shows the presence of a
large 50 kD protein with the pQE30 tag.
SUPPLEMENTARY FIGURE 2 | Individual proteins are more highly expressed in
non-survivor CSF. Distribution (estimates of abundance, y-axis, arbitrary units) of
proteins individually more abundant (p < 0.05) in non-survivors (purple) compared to
survivors (blue), that do not reach significance at the FDR level. Each bar represents
an individual patient. Colors represent individual proteins statistically over-
expressed in non-survivors. Protein identifiers available in the supplementary
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